淋巴结转移和在胸部小细胞食道癌中复发的模式:一个单一机构的经验
Di Liu1,2,3, Xiufang Lv4, Jianjiao Ni1,2,3
1Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Annals of surgical oncology
|October 7, 2025
概括
小细胞食道癌 (SCEC) 显示出积极的淋巴扩散,特别是在腹部淋巴结. 扩展淋巴切除术和辅助化疗改善了这种罕见食道癌症患者的治疗结果.
科学领域:
- 胸部瘤学 胸部瘤学
- 手术瘤学手术瘤学
- 病理学 病理学 病理学
背景情况:
- 主要胸部小细胞食道癌 (SCEC) 是罕见的.
- 了解淋巴结转移 (LNM) 模式对于治疗计划至关重要.
研究的目的:
- 调查SCEC中的LNM模式和相关因素.
- 为了确定治疗性食道切除术后的预后因素和失败模式.
主要方法:
- 对147名接受R0切除的SCEC患者的回顾性审查.
- 后勤回归分析了临床病理变量和LNM之间的关联.
- 考克斯回归评估了对癌症特定存活率 (CSS) 和无病存活率 (DFS) 的影响.
主要成果:
- 68.0%的患者患有LNMs,其中11.3%的切割节点受到影响.
- 腹部LNM是最常见的 (35.4%),特别是在下胸部瘤 (48.0%).
- 淋巴血管侵入,晚期,和<4次化疗周期与较差的存活率相关.
结论:
- SCEC表现出积极的淋巴扩散,对腹部LNMs的倾向高于食道状细胞癌.
- 建议进行扩展性淋巴切除术 (包括复发性神经和腹结).
- 建议至少进行4次辅助化疗,以获得更好的结果.
更多相关视频
05:23Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
1.6K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
489
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
